Reply to: correspondence on "Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis".

Autor: Rezaee-Zavareh MS; Middle East Liver Diseases (MELD) Center, Tehran 1417935840, Iran., Guo Z; Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China; Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), Guangzhou, China., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles 90048, CA, USA; Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles 90048, CA, USA; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles 90048, CA, USA. Electronic address: judong.yang@cshs.org.
Jazyk: angličtina
Zdroj: Journal of hepatology [J Hepatol] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.
DOI: 10.1016/j.jhep.2024.09.019
Databáze: MEDLINE